NEWS
The information contained in each news post on this page was factually accurate on the date it was issued and posted.
Sutro Biopharma Reports Full Year 2019 Financial Results and Recent Business Highlights and Developments
STRO-002 Data from an Ongoing Phase 1 Clinical Trial in Ovarian and Endometrial Cancers Late-Breaking Abstract was accepted by AACR; Sutro plans to announce updated data in second quarter 2020 STRO-001 Phase 1 Clinical Trial and Dose Escalation Ongoing in Multiple...
Sutro Biopharma Announces Extension of First Cytokine Derivative Research Program Under Collaboration with Merck
SOUTH SAN FRANCISCO, Calif., March. 12, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology...
10th Annual World ADC London 2020 – PowerPoint Presentation
To download the presentation, CLICK HERE
Sutro Biopharma to Present Innovative Cancer Therapy Approach Using Precise Tumor Targeted Immunostimulants at World ADC London
SOUTH SAN FRANCISCO, Calif., March. 4, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology...
Sutro Biopharma to Present at the Cowen and Company 40th Annual Health Care Conference
SOUTH SAN FRANCISCO, Calif., Feb. 27, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology...
Sutro Biopharma Expands Senior Management Team with the Appointments of Vice President of Immunobiology and Vice President of Business Development
SOUTH SAN FRANCISCO, Calif., Feb. 5, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology...
Sutro Biopharma to Present at 38th Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 8, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology...
Open Letter From Our CEO
Hi All, For several years I have been troubled by the levels of public antipathy (if not outright scorn) for our industry. Routinely biotech (not just pharma) is held in low esteem by the American public – effectively on a par with the tobacco industry. While I...
Sutro Biopharma Appoints James Panek to Board of Directors
SOUTH SAN FRANCISCO, Calif., Jan. 8, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology...
Cell Free Systems Conference 2019 – Cell-Free Protein Synthesis Scale-Up and GMP Production of Protein Biotherapeutics for Clinical Trials – Poster
Cell Free Systems Conference 2019 - Poster Please click the link to enlarge image, Cell Free Systems Conference 2019